Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary progressive Multiple Sclerosis

S. L. Hauser, L. Kappos, X. Montalban, R. Hughes, H. Koendgen, J. McNamara,A. Pradhan,D. WorMSer, J. S. Wolinsky